2024 – General Nephrology – Diabetes/Cardiovascular/Hypertension

KIDNEY-BONE RESPONSE MODULATES THE EFFECT OF SKELETAL VDR/RXR ON FGF23 SECRETION IN DB/DB MICE Dr Wenjing Wu1, Dr. Lan Wang1, Professor Xinrong Zou1, Professor Xiaoqin Wang1 1Hubei Provincial Hospital of Traditional Chinese Medicine(Affiliated Hospital of Hubei University of Chinese Medcicne),...
  • 10 July 2024
Read More
A CASE OF PREGABALIN INDUCED HYPOGLYCAEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS (T1DM) Dr SALONEE PHANSE1, Dr. NEESAN DAVID1, Dr.  AYE THIN1, Dr. STEPHEN MAY1 1Tamworth Rural Referral Hospital, Tamworth, Australia Background: Hypoglycaemia has been associated with pregabalin...
  • 10 July 2024
Read More
STRATEGIES TO IMPROVE EVIDENCE-BASED CARE DELIVERY IN TYPE 2 DIABETES MELLITUS ACCORDING TO PATIENTS AND MULTIDISCIPLINARY CLINICIANS Dr Daniel O’Hara1,2, Dr Tae Won Yi1,3,4, Professor Meg J Jardine1,5, Professor Rachael L Morton1,6 1NHMRC Clinical Trials Centre, University of Sydney, Camperdown,...
  • 10 July 2024
Read More
PHASE II DOSE-SELECTION, RANDOMIZED, CONTROLLED TRIAL OF ASI BI 690517 WITH AND WITHOUT EMPAGLIFLOZIN IN CHRONIC KIDNEY DISEASE: SUBGROUP ANALYSIS BY TYPE 2 DIABETES STATUS FRANCESCA TANG9, PETER  ROSSING1,2, SIBYLLE HAUSKE3,4, LISA CRONIN5, HIDDO LAMBERS HEERSPINK6,7, JULIANE MEYERHOFF3, SHIMOLI SHAH5,...
  • 10 July 2024
Read More
EXPLORING THE GUT-KIDNEY-AXIS IN A MOUSE MODEL OF DIABETIC KIDNEY DISEASE Miss Amalia S. Khayyira1, Dr. Sih Min Tan1, Dr. Matthew Snelson2, Miss Inez A. Trambas1, Mrs. Adrienne Laskowski1, Dr. Arpeeta Sharma1, Dr.  Melinda T. Coughlan1 1Department of Diabetes, School...
  • 10 July 2024
Read More
SCOPING REVIEW OF BLOOD PRESURE OUTCOMES FOLLOWING ATTENDANCE AT SPECIALIST HYPERTENSION CLINICS DESTINY O’DEA1, ANDREW CHUNG2, ARUNIMA JAIN1,2, AMY KANG1,3, ZOLTAN ENDRE1,2, SRADHA KOTWAL1,2,3 1Department of Nephrology, Prince Of Wales Hospital, Sydney, Australia, 2School of Clinical Medicine, Faculty of Medicine...
  • 10 July 2024
Read More
HNRNPF OVEREXPRESSION EXTENSIVELY REGULATES EXPRESSION AND ALTERNATIVE SPLICING OF TARGET GENES ASSOCIATED WITH THE PROGRESSION OF DIABETIC KIDNEY DISEASE Dr Lan Wang1,2, Huimeng Li1, Xinrong Zou2 1Hubei University of Chinese Medicine, Wuhan, Hubei Province, China, , , 2Hubei Provincial Hospital...
  • 25 June 2024
Read More
DUAL INHIBITION OF COMPLEMENT C5a RECEPTOR 1 AND 2 IN DIABETIC KIDNEY DISEASE Dr Sih Min Tan1, Inez Trambas1, Adrienne Laskowski1, Amalia Khayyira1, Arpeeta Sharma1, Trent Woodruff2, Melinda Coughlan1 1Department of Diabetes, School of Translational Medicine, Monash University, Melbourne, Australia,...
  • 25 June 2024
Read More
ASSOCIATION OF DIABETES AND CHRONIC KIDNEY DISEASE IN YOUNG ABORIGINAL AND NON-ABORIGINAL ADULTS USING LARGE-SCALE LINKED COHORT DATA IN AUSTRALIA: THE ARDAC STUDY ELEONORA DAL GRANDE1, A/Prof. Jacqueline H Stephens1,2,3, KYLIE-ANN MALLITT2,3, AMANDI HIYARE1, SIAH KIM2,3, VICTORIA SINKA2,3, MICHELLE DICKSON2,4,...
  • 25 June 2024
Read More
INCREASING CKD DETECTION IN HIGH RISK COHORTS THROUGH PRACTICE DATA REVIEW, EDUCATION AND IMPLEMENTATION OF A STRUCTURED PRACTICE FRAMEWORK: THE CKD CLINICAL AUDIT Ms BREONNY ROBSON1, MS CLAIRE SHEEKY1 1Kidney Health Australia, Australia Aim: This clinical audit aimed to increase...
  • 25 June 2024
Read More
Categories